Reduced COVID-19 hospitalizations among New York City residents following age-based SARS-CoV-2 vaccine eligibility: Evidence from a regression discontinuity design. (April 2022)

• Record Type: Journal Article
• Authors: Greene, Sharon K.; Levin-Rector, Alison; McGibbon, Emily; Baumgartner, Jennifer; Devinney, Katelynn; Ternier, Alexandra; Sell, Jessica; Kahn, Rebecca; Kishore, Nishant
• Is Part Of: Vaccine. Volume 10(2022)
• Publication Date: 2022-04
• Subjects: Vaccines -- SARS-CoV-2 -- Surveillance -- COVID-19 -- Public Health -- Epidemiology; CI confidence interval -- COVID-19 coronavirus disease 2019 -- DOHMH Department of Health and Mental Hygiene -- NYC New York City -- RR rate ratio -- SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
• DOI: 10.1016/j.jvacx.2021.100134
• Languages: English
• ISSNs: 2590-1362

Abstract

Highlights: For 8 weeks in NYC, age ≥ 65 years was a SARS-CoV-2 vaccine eligibility requirement. We assessed local vaccine effectiveness using a regression discontinuity design. Vaccination reduced COVID-19 hospitalizations among 65–84-year-olds by 15%. Equitable vaccine access is needed to reduce inequities in COVID-19 outcomes. Abstract: Background: In clinical trials, several SARS-CoV-2 vaccines were shown to reduce risk of severe COVID-19 illness. Local, population-level, real-world evidence of vaccine effectiveness is accumulating. We assessed vaccine effectiveness for community-dwelling New York City (NYC) residents using a quasi-experimental, regression discontinuity design, leveraging a period (January 12–March 9, 2021) when ≥ 65-year-olds were vaccine-eligible but younger persons, excluding essential workers, were not. Methods: We constructed segmented, negative binomial regression models of age-specific COVID-19 hospitalization rates among 45–84-year-old NYC residents during a post-vaccination program implementation period (February 21–April 17, 2021), with a discontinuity at age 65 years. The relationship between age and hospitalization rates in an unvaccinated population was incorporated using a pre-implementation period (December 20, 2020–February 13, 2021). We calculated the rate ratio (RR) and 95% confidence interval (CI) for the interaction between implementation period (pre or post) and age-based eligibility (45–64 or 65–84 years). Analyses were stratified by race/ethnicity and borough of residence. Similar analyses were conducted for COVID-19 deaths. Results: Hospitalization rates among 65–84-year-olds decreased from pre- to post-implementation periods (RR 0.85, 95% CI: 0.74–0.97), controlling for trends among 45–64-year-olds. Accordingly, an estimated 721 (95% CI: 126–1, 241) hospitalizations were averted. Residents just above the eligibility threshold (65–66-year-olds) had lower hospitalization rates than those below (63–64-year-olds). Racial/ethnic groups and boroughs with higher vaccine coverage generally experienced greater reductions in RR point estimates. Uncertainty was greater for the decrease in COVID-19 death rates (RR 0.85, 95% CI: 0.66–1.10). Conclusion: The vaccination program in NYC reduced COVID-19 hospitalizations among the initially age-eligible ≥ 65-year-old population by approximately 15% in the first eight weeks. The real-world evidence of vaccine effectiveness makes it more imperative to improve vaccine access and uptake to reduce inequities in COVID-19 outcomes.